Azithromycin 250 MG Oral Capsule

DRUG2 trials

Sponsors

Institut de cancérologie Strasbourg Europe, Hayatabad Medical Complex

Conditions

Acne Vulgaris II or III DegreeCOVID19Hematologic Malignancy

Phase 2

Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE)

WithdrawnNCT04392128

Institut de cancérologie Strasbourg EuropeCOVID19, Hematologic Malignancy

Start: 2020-09-02End: 2020-09-02Updated: 2020-09-04

Phase 4

Comparison of Efficacy of Azithromycin Alone vs Combination of Azithromycin and Probiotics in Management of Mild to Moderate Acne Vulgaris

Active, not recruitingNCT07384793

Hayatabad Medical ComplexAcne Vulgaris II or III Degree

Start: 2025-10-12End: 2026-04-01Target: 60Updated: 2026-02-03